Nanoform Finland Oyj (FRA:4YL)

Market Cap	84.64M
Revenue (ttm)	3.84M
Net Income (ttm)	-21.77M
Shares Out	n/a
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	10
Open	0.9770
Previous Close	0.9190
Day's Range	0.9770 - 0.9770
52-Week Range	0.7380 - 1.4760
Beta	n/a
RSI	39.02
Earnings Date	Feb 26, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 181
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YL

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.